ArticleJournal of translational medicine2022

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma.

Nan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.